过去一年中添加的文章，按日期排序

Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study

TH Liu, MH Chuang, JY Wu, PY Huang… - Journal of Medical …, 2023 - Wiley Online Library
325 天前 - … novel oral antiviral agents, namely NMV-r and molnupiravir… MACEs among
nonhospitalized patients with COVID-19, … COVID-19 infection and those receiving other …
被引用次数：6 相关文章 所有 2 个版本
[HTML] oup.com

Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial

Y Guan, A Puenpatom, MG Johnson… - Clinical Infectious …, 2023 - academic.oup.com
336 天前 - … Molnupiravir is an orally administered antiviral authorized for COVID-19
treatment in … molnupiravir in at-risk, unvaccinated, nonhospitalized adults with laboratory-confirmed …
被引用次数：2 相关文章 所有 7 个版本

Outcomes of hematologic malignancy patients with SARS-CoV-2 breakthrough infections after tixagevimab-cilgavimab during community transmission of monoclonal …

M Kamboj, JC Laracy, S Usiak, NE Babady… - Journal of …, 2023 - journalofinfection.com
343 天前 - … and 2/6 (33%) after molnupiravir treatment. The median time to … Three non-hospitalized
patients with rebound … that COVID-19 rebound symptoms experienced by patients with …
被引用次数：3 相关文章 所有 4 个版本